Immunotherapy, gene editing advances extend to Type 1 Diabetes – Medical Xpress
|
Immunotherapy, gene editing advances extend to Type 1 Diabetes
Medical Xpress Dr. Jane Buckner of the Benaroya Research Institute at Virginia Mason and Dr. David Rawlings at Seattle Children's Research Institute are leading research to develop an immunotherapy for type 1 diabetes. Credit: Seattle Children's. Advances in … |
